Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica Licenses Biopendium to Japan s Riken Center

NEW YORK, July 17 - Inpharmatica has sold a non-exclusive license to its Biopendium proteome-annotation tool to Japanese structural genomics center Riken, the company said today.

Inpharmatica's Tokyo-based partner PharmaDesign will provide Riken with primary training and support over the period of the subscription.
 
Financial terms of the agreement were not disclosed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.